About Erbi Bio
Erbi Bio is a company based in Stoneham (United States) founded in 2016 was acquired by Merck in December 2022.. Erbi Bio has raised $7.8 million across 2 funding rounds from investors including Merck, Jaguar Health and Michael Chambers. Erbi Bio operates in a competitive market with competitors including Proklean Technologies, Limula, PBS Biotech, RheaVita and m2p-labs, among others.
- Headquarter Stoneham, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Software Development Team
17 people
Sales and Marketing
16 people
Senior Team
6 people
Leadership Team
6 people
Project Team
6 people
Human Resources and Administration
5 people
Product Management Team
4 people
Legal and Compliance
3 people
Unlock access to complete
Funding Insights of Erbi Bio
Erbi Bio has successfully raised a total of $7.8M across 2 strategic funding rounds. The most recent funding activity was a Angel Round round of $4 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Angel Round — $4.0M
-
First Round
First Round
(23 Oct 2020)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Angel Round - Erbi Bio | Valuation | Michael Chambers , Martin Madaus |
|
| Oct, 2020 | Amount | Series A - Erbi Bio | Valuation | Jaguar Health |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Erbi Bio
Erbi Bio has secured backing from 4 investors, including angel and institutional investors. Prominent investors backing the company include Merck, Jaguar Health and Michael Chambers. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Novel gastrointestinal products for humans and animals are developed sustainably.
|
Founded Year | Domain | Location | |
|
Merck is engaged in science and technology solutions globally.
|
Founded Year | Domain | Location | |
|
MC
Michael Chambers |
Angel investor focusing on Indian startups, tech enthusiast
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Erbi Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Erbi Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Erbi Bio Comparisons
Competitors of Erbi Bio
Erbi Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proklean Technologies, Limula, PBS Biotech, RheaVita and m2p-labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Probiotic-based cleaning agents are manufactured for industrial use.
|
|
| domain | founded_year | HQ Location |
Modular solutions for on-demand cell therapy manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
|
|
| domain | founded_year | HQ Location |
Instruments for continuous freeze-drying are developed by RheaVita.
|
|
| domain | founded_year | HQ Location |
Micro-bioreactors are provided for screening and bioprocess development.
|
|
| domain | founded_year | HQ Location |
Bioreactors and systems for cultivated meat production are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Erbi Bio
Frequently Asked Questions about Erbi Bio
When was Erbi Bio founded?
Erbi Bio was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Where is Erbi Bio located?
Erbi Bio is headquartered in Stoneham, United States. It is registered at Stoneham, Massachusetts, United States.
Who is the current CEO of Erbi Bio?
Michael Chiu is the current CEO of Erbi Bio.
Is Erbi Bio a funded company?
Erbi Bio is a funded company, having raised a total of $7.8M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.8M, raised on Oct 23, 2020.
What does Erbi Bio do?
Erbi Bio was established in 2016 in Stoneham, United States, within the biotechnology sector. Microbioreactors are produced for research applications, supporting scientific experimentation in controlled environments. Operations are centered on manufacturing these devices, with distribution handled through the companys domain, erbi-bio.com. Leadership is provided by CEO Michael Chiu, overseeing activities in the research tools industry.
Who are the top competitors of Erbi Bio?
Erbi Bio's top competitors include Proklean Technologies, PBS Biotech and RheaVita.
Who are Erbi Bio's investors?
Erbi Bio has 4 investors. Key investors include Merck, Jaguar Health, Michael Chambers, and Martin Madaus.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.